Ab Science Sa Stock Net Asset

AB Stock  EUR 0.82  0.04  5.13%   
AB Science SA fundamentals help investors to digest information that contributes to AB Science's financial success or failures. It also enables traders to predict the movement of AB Science Stock. The fundamental analysis module provides a way to measure AB Science's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AB Science stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AB Science SA Company Net Asset Analysis

AB Science's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Net Asset

 = 

Current Market Value

-

Current Liabilities

More About Net Asset | All Equity Analysis

Current AB Science Net Asset

    
  21.27 M  
Most of AB Science's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AB Science SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Competition

Based on the recorded statements, AB Science SA has a Net Asset of 21.27 M. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers - Major industry. The net asset for all France stocks is notably lower than that of the firm.

AB Science Net Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AB Science's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AB Science could also be used in its relative valuation, which is a method of valuing AB Science by comparing valuation metrics of similar companies.
AB Science is currently under evaluation in net asset category among its peers.

AB Science Fundamentals

About AB Science Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AB Science SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AB Science using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AB Science SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AB Science Stock

AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.